Ismael A Vergara

8PUBLICATIONS
83CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 30, 2025
Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors.

Ismael A Vergara, Nigel G Maher, Alison J Potter

|Feb 15, 2023
Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.

Hansol Lee, Angela L Ferguson, Camelia Quek

|Dec 08, 2022
Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.

James S Wilmott, Hussein Tawbi, Johnathan A Engh

|Sep 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.

Felicity Newell, Peter A Johansson, James S Wilmott

|Mar 05, 2021
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.

Ismael A Vergara, Christopher P Mintoff, Shahneen Sandhu

Pageof 2